Table of Content


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Thrombosis Drug Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing patient awareness regarding thrombosis treatment
5.1.1.2. Surge in prevalence of kidney diseases, stroke, and hypertension
5.1.1.3. Favorable reimbursement scenario for the drugs
5.1.2. Restraints
5.1.2.1. High cost of the medicines and treatment
5.1.3. Opportunities
5.1.3.1. Technological advancements in the treatment and increasing number of retail pharmacies
5.1.3.2. Growing healthcare expenditure and rise of collaborative activities
5.1.4. Challenges
5.1.4.1. Strict drug regulatory systems
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Thrombosis Drug Market, by Drug Class
6.1. Introduction
6.2. Factor Xa Inhibitor
6.3. Heparin
6.4. P2Y12 Platelet Inhibitor

7. Thrombosis Drug Market, by Disease Type
7.1. Introduction
7.2. Atrial Fibrillation
7.3. Deep Vein Thrombosis
7.4. Pulmonary Embolism

8. Thrombosis Drug Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Retail Pharmacies

9. Americas Thrombosis Drug Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Thrombosis Drug Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Thrombosis Drug Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Aspen Pharmacare Holdings Limited by Mylan N.V.
13.1.2. Aurobindo Pharmaceuticals USA, Inc.
13.1.3. B. Braun Melsungen AG
13.1.4. Bayer AG
13.1.5. Becton, Dickinson and Company
13.1.6. Boehringer Ingelheim GmbH
13.1.7. Bristol-Myers Squibb
13.1.8. Cardinal Health, Inc.
13.1.9. GoodRx Holdings, Inc.
13.1.10. Grifols, S.A
13.1.11. Inari Medical, Inc.
13.1.12. ITALFARMACO S.p.A
13.1.13. Johnson & Johnson Services, Inc.
13.1.14. Pfizer, Inc
13.1.15. Sanofi S.A.
13.2. Key Product Portfolio

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures


FIGURE 1. THROMBOSIS DRUG MARKET RESEARCH PROCESS
FIGURE 2. THROMBOSIS DRUG MARKET SIZE, 2023 VS 2030
FIGURE 3. THROMBOSIS DRUG MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. THROMBOSIS DRUG MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. THROMBOSIS DRUG MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. THROMBOSIS DRUG MARKET DYNAMICS
FIGURE 7. THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
FIGURE 8. THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
FIGURE 10. THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS THROMBOSIS DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS THROMBOSIS DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES THROMBOSIS DRUG MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES THROMBOSIS DRUG MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC THROMBOSIS DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC THROMBOSIS DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THROMBOSIS DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA THROMBOSIS DRUG MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. THROMBOSIS DRUG MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. THROMBOSIS DRUG MARKET SHARE, BY KEY PLAYER, 2023

List of Tables


TABLE 1. THROMBOSIS DRUG MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. THROMBOSIS DRUG MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL THROMBOSIS DRUG MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 6. THROMBOSIS DRUG MARKET SIZE, BY FACTOR XA INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. THROMBOSIS DRUG MARKET SIZE, BY HEPARIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. THROMBOSIS DRUG MARKET SIZE, BY P2Y12 PLATELET INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 10. THROMBOSIS DRUG MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. THROMBOSIS DRUG MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. THROMBOSIS DRUG MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 14. THROMBOSIS DRUG MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. THROMBOSIS DRUG MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. THROMBOSIS DRUG MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS THROMBOSIS DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 21. ARGENTINA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 24. BRAZIL THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 27. CANADA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 28. CANADA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 29. CANADA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 30. MEXICO THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 31. MEXICO THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES THROMBOSIS DRUG MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC THROMBOSIS DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. AUSTRALIA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 44. CHINA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 45. CHINA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 46. CHINA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. INDIA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 48. INDIA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 49. INDIA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. INDONESIA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. JAPAN THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 54. JAPAN THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 55. JAPAN THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. MALAYSIA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. PHILIPPINES THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. SINGAPORE THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. SOUTH KOREA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 68. TAIWAN THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 71. THAILAND THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 72. THAILAND THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 73. THAILAND THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. VIETNAM THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA THROMBOSIS DRUG MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 81. DENMARK THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 82. DENMARK THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 83. DENMARK THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. EGYPT THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 85. EGYPT THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 86. EGYPT THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. FINLAND THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 88. FINLAND THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 89. FINLAND THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. FRANCE THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 91. FRANCE THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. GERMANY THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 94. GERMANY THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 95. GERMANY THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 96. ISRAEL THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. ITALY THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 100. ITALY THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 101. ITALY THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. NETHERLANDS THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. NIGERIA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 108. NORWAY THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 109. NORWAY THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 110. NORWAY THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. POLAND THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 112. POLAND THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 113. POLAND THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. QATAR THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 115. QATAR THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 116. QATAR THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. RUSSIA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. SPAIN THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 127. SPAIN THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 128. SPAIN THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. SWEDEN THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. SWITZERLAND THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. TURKEY THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 136. TURKEY THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 137. TURKEY THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. UNITED ARAB EMIRATES THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM THROMBOSIS DRUG MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM THROMBOSIS DRUG MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM THROMBOSIS DRUG MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. THROMBOSIS DRUG MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 145. THROMBOSIS DRUG MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. THROMBOSIS DRUG MARKET LICENSE & PRICING